ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2022

Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy.

Nicholas P Tschernia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.